AdvaMed Urges Defibrillator, Carotid Stent, DES Payment Policy Changes
This article was originally published in The Gray Sheet
Executive Summary
CMS' efforts to "interject debate" over expanded national coverage of defibrillators into the payment realm by soliciting ways to encourage less expensive use of ICDs when clinically valid are inappropriate, AdvaMed says
You may also be interested in...
FY 2005 Medicare Inpatient Payment Rule In Brief
Implantable defibrillator payments: CMS appears to be waiting to determine ICD payments until it issues a decision expanding national coverage based on the SCD-HeFT trial population, expected by year-end. The agency came under heavy fire from industry and professional societies for soliciting comments in the inpatient prospective payment system proposed rule on ways to encourage less expensive use of ICDs when clinically appropriate (1"The Gray Sheet" July 5, 2004, p. 8). The final rule does not discuss stakeholder comments or a final policy...
FY 2005 Medicare Inpatient Payment Rule In Brief
Implantable defibrillator payments: CMS appears to be waiting to determine ICD payments until it issues a decision expanding national coverage based on the SCD-HeFT trial population, expected by year-end. The agency came under heavy fire from industry and professional societies for soliciting comments in the inpatient prospective payment system proposed rule on ways to encourage less expensive use of ICDs when clinically appropriate (1"The Gray Sheet" July 5, 2004, p. 8). The final rule does not discuss stakeholder comments or a final policy...
AdvaMed, MDMA Take Issue With CMS’ New Tech Add-On Payment Policy
CMS' proposed redefinition of "new" technologies contradicts Medicare statute, according to AdvaMed